ZA973062B - New pharmaceutical formulation of a thrombin inhibitor for parenteral use. - Google Patents

New pharmaceutical formulation of a thrombin inhibitor for parenteral use.

Info

Publication number
ZA973062B
ZA973062B ZA9703062A ZA973062A ZA973062B ZA 973062 B ZA973062 B ZA 973062B ZA 9703062 A ZA9703062 A ZA 9703062A ZA 973062 A ZA973062 A ZA 973062A ZA 973062 B ZA973062 B ZA 973062B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical formulation
thrombin inhibitor
parenteral use
new pharmaceutical
new
Prior art date
Application number
ZA9703062A
Inventor
Anna Lundgren
Ulla Stjernfelt
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of ZA973062B publication Critical patent/ZA973062B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ZA9703062A 1996-04-24 1997-04-10 New pharmaceutical formulation of a thrombin inhibitor for parenteral use. ZA973062B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9601556A SE9601556D0 (en) 1996-04-24 1996-04-24 New pharmaceutical formulation of a thrombin inhibitor for parenteral use

Publications (1)

Publication Number Publication Date
ZA973062B true ZA973062B (en) 1997-10-24

Family

ID=20402321

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9703062A ZA973062B (en) 1996-04-24 1997-04-10 New pharmaceutical formulation of a thrombin inhibitor for parenteral use.

Country Status (6)

Country Link
AR (1) AR006664A1 (en)
AU (1) AU2719597A (en)
ID (1) ID17334A (en)
SE (1) SE9601556D0 (en)
WO (1) WO1997039770A1 (en)
ZA (1) ZA973062B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802938D0 (en) * 1998-09-01 1998-09-01 Astra Ab Improved stability for injection solutions
SE9802973D0 (en) * 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
SE9900070D0 (en) * 1999-01-13 1999-01-13 Astra Ab New use
FR2793418B1 (en) * 1999-05-11 2001-07-27 Synthelabo GALENIC FORMULATIONS OF ANTITHROMBOTIC AGENTS FOR SUBCUTANEOUS ADMINISTRATION
SE9902202D0 (en) * 1999-06-10 1999-06-10 Astra Ab Production of aggregates
SE0001803D0 (en) 2000-05-16 2000-05-16 Astrazeneca Ab New compounds i
GB0014134D0 (en) * 2000-06-10 2000-08-02 Astrazeneca Ab Combination therapy
GB0014136D0 (en) * 2000-06-10 2000-08-02 Astrazeneca Ab Combination therapy
PE20020300A1 (en) 2000-08-22 2002-05-10 Pharmacia Corp COMPOSITION OF SOLUTION OF AN ANTIBIOTIC DRUG BASED ON OXAZOLIDINONE WITH IMPROVEMENT OF DRUG LOAD
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
AR035216A1 (en) 2000-12-01 2004-05-05 Astrazeneca Ab MANDELIC ACID DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE DERIVATIVES, USE OF THESE DERIVATIVES FOR THE MANUFACTURE OF MEDICINES, TREATMENT METHODS, PROCESSES FOR THE PREPARATION OF THESE DERIVATIVES, AND INTERMEDIARY COMPOUNDS
SE0101762D0 (en) * 2001-05-18 2001-05-18 Astrazeneca Ab New use
SE0201661D0 (en) 2002-05-31 2002-05-31 Astrazeneca Ab New salts
SE0201658D0 (en) * 2002-05-31 2002-05-31 Astrazeneca Ab Immediate release pharmaceutical formulation
SE0201659D0 (en) * 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
US7479502B2 (en) 2002-12-03 2009-01-20 Pharmacyclics, Inc. 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors
TW200827336A (en) 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
US20150079136A1 (en) * 2012-04-10 2015-03-19 Rubicon Research Private Limited Controlled release pharmaceutical formulations of direct thrombin inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346123A1 (en) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse PHARMACEUTICAL PREPARATIONS OF SUBSTANCES MEDICAL OR UNSTABLE IN WATER AND METHOD FOR THE PRODUCTION THEREOF
DK93993D0 (en) * 1993-08-17 1993-08-17 Finn Molke Borgbjerg USE OF 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN FOR THE PREPARATION OF A SYSTEMIC ANALGETIC OPIOID PREPARATION

Also Published As

Publication number Publication date
SE9601556D0 (en) 1996-04-24
AR006664A1 (en) 1999-09-08
WO1997039770A1 (en) 1997-10-30
AU2719597A (en) 1997-11-12
ID17334A (en) 1997-12-18

Similar Documents

Publication Publication Date Title
HRP960075B1 (en) New thrombin inhibitors
EP0820453A4 (en) Thrombin inhibitors
AU3832895A (en) Thrombin inhibitors
AU3985897A (en) 1,3-diheterocyclic metalloprotease inhibitors
IL128663A0 (en) 1,4-heterocyclic metalloprotease inhibitors
PL326508A1 (en) Protease inhibitors
EP0969840A4 (en) Thrombin inhibitors
ZA973062B (en) New pharmaceutical formulation of a thrombin inhibitor for parenteral use.
AU4787596A (en) Thrombin inhibitors
AU3102397A (en) Metalloprotease inhibitors
EP0927035A4 (en) Thrombin inhibitors
AU7497596A (en) Thrombin inhibitors
EP0971891A4 (en) Thrombin inhibitors
HRP970441B1 (en) New thrombin inhibitors
IL128665A0 (en) Bidenatate metalloprotease inhibitors
AU7139598A (en) Protease inhibitors
AU4641097A (en) New pharmaceutical parenteral formulation of a thrombin inhibitor
AU3396697A (en) Thrombin inhibitor
AU3042697A (en) Thrombin inhibitors
PL346842A1 (en) New pharmaceutical uses for nos inhibitors
AU2908197A (en) Thrombin inhibitors
IL128107A0 (en) Pharmaceutical compositions containing a pkc inhibitor
AU4618197A (en) Thrombin inhibitors
EP1017383A4 (en) Thrombin inhibitors
AU7252398A (en) Protease inhibitors